Sharenet Sites 
Sharenet Sites
Notification of Major Interest in Mediclinic International plc shares
Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
8 May 2018
Notification of Major Interest in Mediclinic International plc shares
1a. Identity of the issuer or the underlying issuer Mediclinic International plc.
of existing shares to which voting rights are
attached(ii):
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligation
Coronation Asset Management (Pty) Ltd acting as discretionary
Name investment manager on behalf of managed portfolios.
City and country of registered office (if applicable) Cape Town, South Africa
4. Full name of shareholder(s) (if different from 3.)(v)
Name N/A
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or
reached(vi): 7 May 2018
6. Date on which issuer notified (DD/MM/YYYY): 7 May 2018
7. Total positions of person(s) subject to the notification obligation
% of voting rights
% of voting rights through financial Total number of
attached to shares instruments Total of both in % voting rights of
(total of 8. A) (total of 8.B 1 + 8.B 2) (8.A + 8.B) issuer(vii)
Resulting situation
on the date on which 4.92% 4.92% 737 243 810
threshold was
crossed or reached
Position of previous
notification (if 5.01% 5.01%
applicable)
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached(viii)
A: Voting rights attached to shares
Class/type of Number of voting rights(ix) % of voting rights
shares
ISIN code (if possible) Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) (DTR5.1) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.2.1) (DTR5.2.1)
GB00B8HX8Z88 36 248 868 4.92%
SUBTOTAL 8. A 36 248 868 4.92%
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Number of voting rights
Type of financial Expiration Exercise/ that may be acquired if
instrument date(x) Conversion Period(xi) the instrument is % of voting rights
exercised/converted.
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive
2004/109/EC (DTR5.3.1.1 (b))
Exercise/ Physical or
Type of financial Expiration Conversion cash Number of
instrument date(x) Period (xi) settlement(xii) voting rights % of voting rights
SUBTOTAL
8.B.2
9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not
control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity xiv X
(please add additional rows as necessary)
% of voting rights
% of voting rights through financial Total of both if it
if it equals or is instruments if it equals or is higher
Name(xv) higher than the equals or is higher than the notifiable
notifiable threshold than the notifiable threshold
threshold
Coronation Fund Managers Ltd
Coronation Investment Management
SA (Pty) Ltd
Coronation Asset Management (Pty)
Ltd 4.92% 4.92%
10. In case of proxy voting, please identify:
Name of the proxy holder Coronation Asset Management (Pty) Ltd
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information(xvi)
Name: Stephan Kemp
Email: skemp@coronation.co.za
Telephone: +27 21 680 2000
Place of completion Cape Town, South Africa
Date of completion 7 May 2018
Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary
listings on the JSE in South Africa and the NSX in Namibia.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott – UK
+44 (0)20 3727 1000
Sherryn Schooling – South Africa
+27 (0)21 487 9000
Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
Date: 08/05/2018 11:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
